Bionomics Limited Stock Earnings Per Share
| BNOEFDelisted Stock | USD 0.01 0.00 0.00% |
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Earnings Per Share Analysis
Bionomics' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Bionomics Earnings Per Share | (0.01) X |
Most of Bionomics' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Bionomics Limited has an Earnings Per Share of -0.012 times. This is 100.14% lower than that of the Healthcare sector and 99.75% lower than that of the Biotechnology industry. The earnings per share for all United States stocks is 100.38% higher than that of the company.
Bionomics Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in earnings per share category among its peers.
Bionomics Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (2.91) % | |||
| Current Valuation | 27.83 M | |||
| Shares Outstanding | 1.35 B | |||
| Shares Owned By Insiders | 6.00 % | |||
| Shares Owned By Institutions | 48.96 % | |||
| Price To Earning | (34.09) X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 8.29 X | |||
| Revenue | 263.63 K | |||
| Gross Profit | (9.94 M) | |||
| EBITDA | (21.92 M) | |||
| Net Income | (21.76 M) | |||
| Cash And Equivalents | 33.56 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 693.62 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 12.46 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (21.76 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 22 | |||
| Beta | 2.18 | |||
| Market Capitalization | 29.11 M | |||
| Total Asset | 65.31 M | |||
| Retained Earnings | (103 M) | |||
| Working Capital | 47 M | |||
| Current Asset | 58 M | |||
| Current Liabilities | 11 M | |||
| Z Score | 23.2 | |||
| Net Asset | 65.31 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |